Table 1.
Demographic and clinical characteristics of participants, by results of TB symptom screen at enrolment
| No TB Symptoms at Baseline N = 976 (74%) | Any TB Symptoms at Baseline N = 349 (26%) | Total N = 1325 | |
|---|---|---|---|
| Country site | |||
| South Africa | 698 (72) | 222 (64) | 920 (69) |
| Uganda | 278 (28) | 127 (36) | 405 (31) |
| Sex | |||
| Male | 256 (26) | 123 (35) | 379 (28) |
| Female | 720 (74) | 226 (65) | 946 (71) |
| Age | |||
| 16 to 24 | 201 (21) | 66 (19) | 267 (20) |
| 25 to 34 | 432 (44) | 128 (37) | 560 (42) |
| >34 | 343 (35) | 155 (44) | 498 (38) |
|
Median (IQR) CD4 (N = 1019) |
510 (377 to 676) (N = 757) |
441 (302 to 621) (N = 262) |
500 (355 to 654) |
| Taking TB treatment at enrolment | 3 (0.3) | 7 (2) | 10 (0.75) |
| Median number TB Symptoms (IQR) | 0 | 2 (1 to 2) | 0 (0 to 1) |
| TB Symptoms reported | |||
| Cough | – | 135 (39) | |
| Fever | – | 169 (48) | |
| Night Sweats | – | 153 (44) | |
| Loss of appetite | – | 190 (54) | |
| Visited HIV care facility (linkage by month 9) | 894 (92) | 324 (93) | 1218 (92) |
| Diagnosis of TB | |||
| South Africa | 11 (2) | 13 (6) | 24 (3) |
| Uganda | 0 (0) | 2 (2) | 2 (1) |